Advertisement
News
Advertisement

Spencer board in favor of buyout

Fri, 11/12/2010 - 10:34am
Mass High Tech: The Journal of New England Technology

The board of directors at Spencer Pharmaceutical Inc. have indicated in a press release that they are in favor of the unsolicited buyout offer it received for 97 cents per share.

The offer was made last week by an as-yet-unnamed purchaser. On Thursday, Spencer Pharmaceutical officials noted the price of the offer, which amounts to about $245 million, as well as the potential buyer’s plan to take the Boston metabolic disease-focused firm private.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading